A5024730291- Advanced Radiotherapy Techniques
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Surgical Treatments
- Medical Imaging Techniques and Applications
- Advances in Oncology and Radiotherapy
- Management of metastatic bone disease
- Colorectal and Anal Carcinomas
- Radiation Therapy and Dosimetry
- Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Radiomics and Machine Learning in Medical Imaging
- Radiation Dose and Imaging
- Colorectal Cancer Screening and Detection
- Spinal Fractures and Fixation Techniques
- Cancer, Hypoxia, and Metabolism
- Colorectal Cancer Treatments and Studies
- Cancer, Lipids, and Metabolism
- Spine and Intervertebral Disc Pathology
- Salivary Gland Tumors Diagnosis and Treatment
- Effects of Radiation Exposure
- Brain Metastases and Treatment
- Bladder and Urothelial Cancer Treatments
- Hepatocellular Carcinoma Treatment and Prognosis
Consorcio Hospitalario Provincial de Castellón
2010-2025
Fundación Hospital Provincial de Castellón
2011-2024
Hospital General Universitari de Castelló
2018-2020
Ferrer Grupo (Spain)
2020
Economic History Society
2020
Hospital Clínico Universitario de Valencia
2011
Fundación Instituto Valenciano de Oncología
2008
Hospital Universitario Son Dureta
2006
Hospital General de Catalunya
2006
Universitat de Barcelona
2006
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% patients with CRC will have metastases at time diagnosis, more than 50% develop metastatic disease during course their disease. A group experts from Spanish Society Medical Oncology, Association Surgeons, Radiation Vascular Interventional Radiology, Nuclear Medicine Molecular Imaging met to discuss provide multidisciplinary consensus on management liver in CRC. The defined...
Palliative radiotherapy (RT) is an effective treatment for symptomatic bone metastases. Pain flare, a transient worsening of the pain after RT, has been described in previous reports with different incidence rates. The aim study was to prospectively evaluate flare following RT painful metastases and its effects on control functionality patients. Between June 2010 2014, 204 patients were enrolled this 135 complete data evaluable. defined as 2- point increase worst score compared baseline no...
Background: The management of metastatic hormone-sensitive prostate cancer (mHSPC) has evolved significantly in recent years due to the introduction androgen receptor-targeted agents (ARTAs). When used alongside deprivation therapy (ADT), these treatments have shown improved oncological results and enhanced survival rates for patients with this condition. Objectives: objective study was describe decline prostate-specific antigen (PSA), outcomes, toxicity profile mHSPC treated apalutamide....
Background: Identifying prostate cancer (PCa) patients with a worse prognosis and higher risk of biochemical recurrence (BCR) is essential to guide treatment choices. Here, we aimed identify possible imaging biomarker (perfusion/diffusion + radiomic features) profiles extracted from MRIs that were able discriminate according their or the occurrence BCR 10 years after diagnosis, as well evaluate predictive value without clinical data. Methods: Patients localized PCa receiving neoadjuvant...
Pilonidal sinus is a very common disease. Malignant transformation occurs in 0,1% of patients. We present case squamous cell carcinoma arised from recurrent pilonidal disease, managed by multimodal treatment. 70-year-old man with chronic sinus. Inflammation had worsened previous months and exploration revealed large ulcerative mass which biopsy showed carcinoma. CT scan MRI imaging tumoral invasion the coccyx both gluteus major muscles. Neoadjuvant radiotherapy, chemotherapy as...
The increase in the global incidence of cancer highlights need to continue advancing techniques diagnosis and nutritional assessment patients, given prognostic therapeutic impact status. In this study, sarcopenia was evaluated as an independent predictor morbidity mortality. Data from 45 patients diagnosed with esophagogastric or pancreatic were analyzed. Body composition determined using computed tomography images, functionality tests performed. Sarcopenia present 22.2% while only 31.1% had...
Intraoperative electron radiotherapy (IOERT) is a highly selective technique which aims to treat restricted anatomic volumes during oncological surgery and now the subject of intense re-evaluation. In vivo dosimetry has been recommended for IOERT identified as risk-reduction intervention in context an risk analysis. Despite reports fruitful experiences, information about intraoperative somewhat scarce. Therefore, aim this paper report our experience developing program IOERT, from both...
In vivo dosimetry is recommended in intraoperative electron radiotherapy (IOERT). To perform real-time treatment monitoring, action levels (ALs) have to be calculated. Empirical approaches based on observation of samples been reported previously, however, our aim present a predictive model for calculating ALs and verify their validity with experimental data. We considered the range absorbed doses delivered detector by means percentage depth dose beams used. Then, we calculated histograms...
Abstract Introduction To evaluate whether age is a predictor of pain response after radiotherapy for painful bone metastasis (BM). Methods Between June 2010 and 2014, 204 patients with BM undergoing palliative participated in multicentre prospective study. Patients completed the Brief Pain Inventory (BPI) to rate intensity (from 0 10) at baseline 4 weeks radiotherapy. determine which variables predicted particularly predictor, logistic regression analysis was used. Baseline considered were:...
Care overburden makes it difficult to perform comprehensive geriatric assessments (CGAs) in oncology settings. We analyzed if screening tools modified radiotherapy oncogeriatric patients. Patients ≥ 65 years, irradiated between December 2020 and March 2021 at the Hospital Provincial de Castellón, completed frailty G8 estimated survival Charlson questionnaires. The cohort was stratified score ≤ 14 (fragile) or >14 (robust); cutoff point for index established five. Of 161 patients; 69.4% were...
The aim of this study was to develop a deformable image registration (DIR)-based offline ART protocol capable identifying significant dosimetric changes in the first treatment fractions determine when adaptive replanning is needed. A total 240 images (24 planning CT (pCT) and 216 kilovoltage cone-beam (CBCT)) were prospectively acquired from 24 patients with prostate adenocarcinoma during three weeks their (76 Gy 38 fractions). This set used plan hypofractionated virtual (57.3 15 fractions);...
Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer.We analysed the toxicity and clinical control results obtained patients bone-only oligometastatic cancer treated stereotactic ablative radiotherapy (SABR). Retrospective study on metachronous oligoprogression synchronous de novo SABR androgen deprivation therapy.Treatment schedules varied according location organs at risk, biologically...